Company Monitoring Page for AstraZeneca

latest headlines for company on cafepharma

AstraZeneca, Novo Nordisk and Sanofi score 340B-related appeals court win over HHS
Endpoints
Mon, 01/30/23 - 05:58 pm
Tags:
AstraZeneca, Sanofi, Novo Nordisk, 340B, drug discounts
Bristol Myers doubles down in immuno-oncology patent fight with AZ, this time targeting Imjudo
Fierce Pharma
Tue, 01/24/23 - 06:31 pm
Tags:
Bristol Myers Squibb, legal, AstraZeneca, Imjudo, Yervoy, cancer, patents
AstraZeneca, Merck go multilingual for prostate cancer push
Medical Marketing and Media
Mon, 01/23/23 - 09:54 pm
Tags:
AstraZeneca, Merck, pharma marketing, prostate cancer
AstraZeneca Will Withdraw Leukemia Drug Lumoxiti From US Market
MPR
Thu, 01/12/23 - 09:23 pm
Tags:
AstraZeneca, Lumoxiti, leukemia
Biopharma’s bolt-on bonanza is set to continue
EP Vantage
Thu, 01/12/23 - 10:18 am
Tags:
M&A, Amgen, AstraZeneca, Bristol Myers Squibb, GSK, Ipsen, Merck, Pfizer
JPM23: Ionis CEO admits PCSK9 ship captained by Big Pharmas may have sailed
Fierce Biotech
Wed, 01/11/23 - 11:02 pm
Tags:
Ionis Pharmaceuticals, AstraZeneca, ION449
AstraZeneca and Avillion win approval for new asthma rescue treatment in adults
Endpoints
Wed, 01/11/23 - 10:53 am
Tags:
AstraZeneca, Avillion, Airsupra, asthma, FDA
Trio of biotech buyouts jumpstarts J.P. Morgan healthcare meeting
BioPharma Dive
Mon, 01/9/23 - 10:43 am
Tags:
JPMHC 2023, M&A, AstraZeneca, CinCor, Ipsen, Albireo, Chiesi Farmaceutici, Amryt Pharma
AstraZeneca Buys CinCor in a Deal Worth Up to $1.8B
BioSpace
Mon, 01/9/23 - 10:41 am
Tags:
AstraZeneca, CinCor Pharma, M&A
Novo Nordisk, AstraZeneca and Lilly will top pharma's revenue growth in 2023: report
Fierce Pharma
Sun, 01/8/23 - 09:57 pm
Tags:
Pfizer, Merck, JNJ, Novo Nordisk, AstraZeneca
FDA starts review of Sanofi, AZ antibody for RSV prevention
Pharmaphorum
Thu, 01/5/23 - 10:20 am
Tags:
RSV, Sanofi, AstraZeneca, FDA, antibodies, nirsevimab
COVID-19 tracker: AstraZeneca workers who were fired for refusing vaccine file lawsuit
Fierce Pharma
Wed, 01/4/23 - 10:06 am
Tags:
AstraZeneca, vaccines, COVID-19, age discrimination, legal
10 clinical trials to watch in the first half of 2023
BioPharma Dive
Tue, 01/3/23 - 10:57 am
Tags:
clinical trials, Alzheimer's disease, obesity, Huntington's disease, M&A, AstraZeneca, Daiichi Sankyo, Nimbus Therapeutics, Takeda, Eli Lilly, Sanofi, Regeneron, Moderna Therapeutics, Gilead Sciences, Pfizer, Roivant, Alnylam, uniQure
AstraZeneca, Merck's Lynparza wins EU nod in advanced prostate cancer right after FDA delay
Fierce Pharma
Wed, 12/21/22 - 12:40 pm
Tags:
AstraZeneca, Merck, Lynparza, Europe, prostate cancer, advanced prostate cancer
Could AstraZeneca's Asthma Drug Candidate Generate Billions?
Motley Fool
Tue, 12/20/22 - 10:44 am
Tags:
AstraZeneca, asthma, PT027
Despite Imfinzi fail in lung cancer trial, AZ 'encouraged' by one result: exec
Fierce Pharma
Mon, 12/19/22 - 12:29 pm
Tags:
AstraZeneca, Imfinzi, lung cancer, non-small cell lung cancer
Big pharma’s new year catalysts
EP Vantage
Mon, 12/19/22 - 11:05 am
Tags:
AstraZeneca, Daiichi Sankyo, Pfizer, Roche, CSL, uniQure, Novo Nordisk, Eli Lilly
AZ wins patent fight with Viatris, gains more exclusivity for blockbuster Symbicort
Fierce Pharma
Fri, 12/16/22 - 11:08 am
Tags:
AstraZeneca, Symbicort, patents, Viatris
AstraZeneca's Alexion hopes to extend dominance in PNH as Big Pharma competitors close in
Fierce Biotech
Fri, 12/16/22 - 10:47 am
Tags:
AstraZeneca, Alexion, PNH, Ultomiris, Soliris, Roche, Apellis, Novartis
AstraZeneca, Merck hit with 3-month delay for Lynparza's FDA filing in first-line prostate cancer
Fierce Pharma
Thu, 12/15/22 - 11:01 am
Tags:
AstraZeneca, Merck, Lynparza, FDA, metastatic castration-resistant prostate cancer

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.